New Zealand markets closed

Insulet Corporation (PODD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
204.10+4.79 (+2.40%)
At close: 04:00PM EDT
205.00 +0.90 (+0.44%)
After hours: 06:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close199.31
Open200.00
Bid204.02 x 700
Ask204.56 x 500
Day's range199.47 - 204.40
52-week range125.82 - 298.95
Volume1,052,421
Avg. volume836,016
Market cap14.295B
Beta (5Y monthly)1.14
PE ratio (TTM)61.29
EPS (TTM)3.33
Earnings date06 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est233.07
  • Business Wire

    Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

    ACTON, Mass., June 21, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today shared positive results from its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) type 2 diabetes pivotal trial at the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando, Florida. This landmark study evaluated the impact of AID in a diverse group of people with type 2 diabetes who req

  • Insider Monkey

    Insulet (PODD) Faces Increasing Competition

    ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The positive momentum in 2023 continued in the first quarter of 2024, the stocks surged on the expectation of a soft landing of the economy and a slowdown in rate […]

  • Zacks

    Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

    Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.